Ascendiant Capital Markets Lowers Sintx Technologies (NASDAQ:SINT) Price Target to $12.00

Sintx Technologies (NASDAQ:SINT) had its price objective lowered by equities research analysts at Ascendiant Capital Markets from $16.00 to $12.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the stock. Ascendiant Capital Markets’ target price points to a potential upside of 351.13% from the company’s current price.

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Sintx Technologies in a report on Thursday, January 22nd. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Sintx Technologies presently has an average rating of “Hold” and an average target price of $12.00.

Sintx Technologies Stock Performance

SINT opened at $2.66 on Wednesday. The firm has a 50 day moving average price of $2.82 and a 200 day moving average price of $3.42. The company has a market cap of $10.96 million, a PE ratio of -0.47 and a beta of 0.66. Sintx Technologies has a 1 year low of $1.71 and a 1 year high of $6.78.

Institutional Investors Weigh In On Sintx Technologies

Institutional investors have recently bought and sold shares of the business. Geode Capital Management LLC lifted its holdings in shares of Sintx Technologies by 33.5% during the 2nd quarter. Geode Capital Management LLC now owns 15,339 shares of the company’s stock valued at $49,000 after buying an additional 3,848 shares during the last quarter. Veracity Capital LLC increased its position in shares of Sintx Technologies by 10.3% during the third quarter. Veracity Capital LLC now owns 79,928 shares of the company’s stock valued at $327,000 after purchasing an additional 7,464 shares during the period. Finally, Virtus Wealth Solutions LLC bought a new stake in Sintx Technologies in the third quarter valued at $388,000. 18.38% of the stock is currently owned by institutional investors and hedge funds.

Sintx Technologies Company Profile

Sintx Technologies, Inc (NASDAQ: SINT) is a medical materials company specializing in the development and manufacture of silicon nitride-based biomaterials for surgical and implantable medical devices. Its proprietary silicon nitride ceramic combines mechanical strength, biocompatibility and intrinsic antimicrobial properties, positioning it as an alternative to traditional metal and polymer implant materials. Sintx’s primary focus is on applications in spinal fusion, trauma fixation and dental implantology, where device performance and long-term biological response are critical.

The company’s core product offerings include silicon nitride powders for advanced implant fabrication and finished implantable components designed for interbody spinal fusion cages, spinal fixation hardware and trauma plates and screws.